GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.92+0.05 (+2.95%)
Close on Nov 16, 2026Market cap $86.87MP/E –Yield –
Genelux EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Genelux
Genelux has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?